MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib
Keyword(s):
Keyword(s):
2012 ◽
2009 ◽
2018 ◽
Vol 1
(1)
◽
pp. 51-54
2021 ◽
Vol 79
◽
pp. 206-209